651. FGF1 protects against APAP-induced hepatotoxicity via suppression of oxidative and endoplasmic reticulum stress.
- Author
-
Wang X, Zhang X, Wang F, Pang L, Xu Z, Li X, Wu J, Song Y, Zhang X, Xiao J, Lin H, and Liu Y
- Subjects
- Animals, Endoplasmic Reticulum Stress drug effects, Fibroblast Growth Factor 1 pharmacology, Male, Mice, Mice, Inbred C57BL, Oxidative Stress drug effects, Acetaminophen adverse effects, Chemical and Drug Induced Liver Injury etiology, Chemical and Drug Induced Liver Injury prevention & control, Endoplasmic Reticulum Stress physiology, Fibroblast Growth Factor 1 physiology, Fibroblast Growth Factor 1 therapeutic use, Oxidative Stress physiology
- Abstract
Acetaminophen (APAP) overdose/abuse is the leading cause of acute liver failure in many countries. Fibroblast growth factor 1 (FGF 1) is a metabolic regulator with several physiological functions. Previous studies suggested that FGF1 promotes differentiation and maturation of liver-derived stem cells. In this study, we investigated the protective effects of FGF1 against APAP-induced hepatotoxicity in mice. APAP markedly increased circulating levels of ALT and AST, while FGF1 significantly inhibited increases in the serum levels of ALT and AST, as compared to littermates. In addition, histopathological evaluation of the livers revealed that FGF1 prevented APAP-induced centrilobular necrosis. Livers exhibited severe inflammation, apoptosis, oxidative stress and endoplasmic reticulum stress in response to APAP toxicity, whereas these changes were reversed by a single injection of FGF1. In conclusion, our findings suggest that FGF1 protects mice from APAP-induced hepatotoxicity through suppression of inflammation, apoptosis, and oxidative and endoplasmic reticulum stress. Therefore, FGF1 may represent a promising therapeutic agent for APAP-induced acute liver injury., (Copyright © 2019. Published by Elsevier Masson SAS.)
- Published
- 2019
- Full Text
- View/download PDF